PHI with Elevated transaminases
How does this condition affect your private health insurance?
Transaminasenerhöhung, or elevated transaminases (ALT and AST), is not a disease itself but a common indicator of liver cell damage or injury. These enzymes are primarily located in the liver, and their release into the bloodstream signals that liver cells are being harmed. Causes range widely, from mild conditions like fatty liver disease or medication side effects to more severe issues such as viral hepatitis (A, B, C), alcohol-induced liver damage, autoimmune hepatitis, or even acute liver failure. Further diagnostic investigation is always required to identify the specific underlying etiology and determine the appropriate course of treatment.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 25%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Days to several weeks, depending on the underlying cause and its acuity.
Duration of Illness (Lifetime)
Can be a one-time acute event or a chronic, lifelong condition, entirely dependent on the underlying cause and its management.
Cost of Treatment (Initial)
Moderate (initial diagnostic workup including blood tests, imaging, and specialist consultations). Costs significantly increase if the underlying cause is severe or requires hospitalization.
Cost of Treatment (Lifetime)
Highly variable, from minimal (if transient and resolved) to very high (for chronic liver diseases requiring ongoing medication, monitoring, or potentially liver transplantation).
Mortality Rate
Low directly from transaminase elevation itself; high if indicative of severe acute liver failure or end-stage chronic liver disease that is unmanaged.
Risk of Secondary Damages
Low directly; high if the underlying liver disease progresses untreated, leading to complications like cirrhosis, liver failure, portal hypertension, or liver cancer.
Probability of Full Recovery
High for mild, transient elevations with treatable causes (e.g., medication discontinuation, lifestyle changes for fatty liver); moderate to low for chronic or severe liver diseases where complete recovery without consequences may not be achievable.
Underlying Disease Risk
Very high, as transaminase elevation is always a symptom of an underlying liver-related or systemic condition. Common underlying diseases include fatty liver, viral hepatitis, alcohol-related liver disease, drug-induced liver injury, and autoimmune hepatitis.